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Summary 
Governments, funding agencies, academic institutions, and health care policy makers 
are increasingly investing in the design, development, and dissemination of 
systematic reviews (SRs) to inform clinical practice guidelines, ethical guidance of 
clinical research, and health care practice and policy. SRs need to be sensitive to the 
dynamic nature of new evidence, such as published papers. The emergence of new 
evidence over time may undermine the validity of conclusions and recommendations 
in any given SR and subsequent practice guideline. This issue has only started to be 
more seriously considered during the last decade or so. Now it is clear that the use of 
out-dated evidence can lead to a waste of resources, provision of redundant, 
ineffective or even harmful health care.  
 
The author of this dissertation and his colleagues conducted and published three 
empirical studies and two conceptual articles (in six peer-reviewed journal 
publications), which addressed the methodologic aspects of when and how to update 
SRs. This PhD project provides a summary of these publications. The work 
described herein has had a significant impact on raising awareness and initiating new 
research efforts for keeping SRs up-to-date.  
 
Publication 1 proposed the first formal definition of what constitutes an update of a 
SR. The article presented distinguishing features of an updated vs. not updated or a 
new review. Publication 2 (or Publication 3) systematically reviewed methods, 
techniques, and strategies describing when and how to update SRs (Study #1). 
Publication 4, an international survey (Study #2), identified and described updating 
practices and policies of organisations involved in the production and commission of 
SRs. Publication 5 reviewed the knowledge and efforts in updating SRs and provided 
guidance for authors and SR groups as to when and how to update comparative 
effectiveness reviews produced by the Agency for Healthcare Research and 
Quality’s (AHRQ) Evidence-based Practice Centres (EPCs) throughout North 
America. Publication 6 (Study #3) described the development, piloting, and 
feasibility of a surveillance system to assess the need for updating comparative 
effectiveness reviews produced by the AHRQ’s EPC Program. This surveillance 
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method has proved to be an efficient approach for prioritising SRs with respect to 
updating need.     
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1. Background   
1.1. Systematic reviews: their role and importance 
Professionals involved in the delivery of health care are faced with the challenge of 
how best to keep themselves up-to-date with advances in their speciality. Continuous 
professional education and quality improvement carried out in health care systems 
should be based on the totality of available up-to-date evidence [1-3]. An efficient 
use of reading time would be to review a single report that synthesizes the findings 
of many individual studies. Systematic reviews (SRs), alone or incorporated into 
clinical guidelines, fulfil this function.  
 
A SR is an explicit form of evidence summary which addresses one or more clearly 
formulated questions for any given health problem by synthesising empirical results 
of relevant primary research studies [4]. Ideally, any SR should be based on a pre-
defined transparent protocol aimed at minimizing or avoiding bias, which details a 
precise and clear evidence-based search methodology to identify and retrieve the 
global evidence, subjecting it to specific eligibility criteria, appraising, and 
summarizing the results of studies qualitatively or quantitatively [3, 5].     
 
Over the past two decades, SRs have become integral building blocks and 
components of health technology assessments (HTAs) and clinical practice 
guidelines (CPGs). They help to fill in the gaps between empirical evidence and 
healthcare decisions. Therefore, governments, health policy makers, patients, and 
other stakeholders are increasingly involved in the commission, design, production, 
and/or use of findings from SRs to inform their decision-making process [6-9]. 
Besides, SRs help to identify gaps in evidence, highlight unmet needs, and prevent 
or minimise redundant research [10]. SRs may also inform ethical and 
methodological issues for designing future primary studies [11, 6]. SRs, HTAs, 
comparative effectiveness reviews (CERs), other types of evidence syntheses are 
conducted by either small teams of researchers or large organisations such as 
Cochrane (global network), the National Institute for Health and Care Excellence 
(NICE) in the UK, the Agency for Healthcare Research and Quality (AHRQ) in the 
US, and the Canadian Agency for Drugs and Technologies in Health (CADTH) in 
Canada.    
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1.2. Keeping systematic reviews up-to-date 
The value of SRs is maximised when they are up-to-date [12, 7, 13, 14]. As evidence 
base of health science is continually evolving with the emergence of new research, 
some health care interventions currently believed to be effective and safe may in 
future be shown to be ineffective or harmful or vice versa [7, 15, 16]. Moreover, 
evidence on new population subgroups, interventions (e.g., oral glycoprotein IIb/IIIa 
inhibitors), and health outcomes (e.g., quality of life scales) will emerge and 
modifications in dosing of interventions or improving surgical skills will take place 
over time [7, 17]. Ignoring these changes could undermine the validity of 
conclusions in SRs and CPGs, thereby compromising healthcare policy decisions. 
Lack of attention to updating any given evidence-base may lead to a waste of 
resources, redundant research, ineffective and sometimes harmful healthcare delivery 
[14]. Additional advantages of updating SRs may be to a) increase the precision 
around a pooled effect estimate [17], b) incorporate delayed publications or grey 
literature to minimise the effects of time lag bias or publication bias [18], c) correct 
errors or typographical errors in the published version, d) incorporate relevant 
evidence (original searches may have missed some relevant studies) [14], e) improve 
methodological and reporting quality of a review [19], and f) ensure overviews 
incorporate SRs that are up-to-date [20]. 
 
In light of the growing number of new primary studies, the issue of keeping SRs up-
to-date becomes even more relevant, although challenging. For example, Bastian and 
colleagues showed that in 2007, there were 11 SRs and 75 trials published daily [21]. 
Similarly, Moher and colleagues identified 300 SRs indexed in Medline during 
November of 2004 with a corresponding estimated publication rate of 2,500 reviews 
per year [22]. A recent study [23] estimated that more than 8,000 SRs were indexed 
in Medline in 2014, corresponding to a 3-fold increase over the last decade in 2004. 
The empirical evidence on the consequences of updating SRs with respect to their 
content and conclusions has been conflicting. Some studies indicating important 
changes in conclusions and others showing no such changes in most of the updated 
SRs [24, 16, 25-28, 17, 29].  
 
Shojania and colleagues defined several quantitative (e.g., change in statistical 
significance of the pooled estimate if a meta-analysis is updated with a new study) 
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and qualitative (e.g., a new harm, a new alternative therapy) signals indicating when 
any given SR needs to be updated (‘the Ottawa method’) [24]. The application of 
these signals to 100 SRs showed that the median time to either of these signals 
indicating the need for updating a SR after its publication was 5.5 years (95% CI: 
4.6, 7.6). However, 23 of the SRs had signals indicating the need for updating within 
two years, 15 within one year, and seven at the time of publication. The odds of 
signals for updating were significantly higher for cardiovascular topics than for other 
topics [24]. A survey of 101 Cochrane childbirth reviews (issue 3, 2007) found a 
shorter updating interval, i.e., the median time to the first update to be 3.3 years 
(95% CI: 2.7, 3.8) with any quantitative changes in 71% of the reviews that included 
new studies [27]. Similarly, the study by Peterson and colleagues demonstrated a 
mean of 24.9 (standard error of 1.96) months to an update based on the analysis of 
41 drug CERs that were commissioned by the Drug Effectiveness Review Project 
(DERP), a collaboration between US Medicaid agencies and the CADTH [30]. 
Higgins and colleagues surveyed 481 Cochrane reviews in the 1998 issue 4 of the 
Cochrane Library of which 65 had included at least one new study since their 
publication. The statistically significant pooled Peto’s odds ratio (OR) was changed 
to non-significant for 26% and vice versa for 69% of the 65 updated reviews [26]. 
French and colleagues followed-up 362 Cochrane reviews from their original 
publication in 1998 to 2002 and found that 70% of them had been updated during the 
4-year period. Only 9% of the updated reviews had a ‘major change’ (‘changes that 
alter the substance or meaning of a section or alter the interpretation’) in their 
conclusions [25]. Three other studies demonstrated similar findings, showing no 
major changes in the effect estimates of updated SRs [29, 28, 17]. 
 
1.3. Barriers to updating systematic reviews  
The importance of the methodology for updating SRs has not been well recognised 
until the last decade. For example, the relative paucity of well-elaborated methods 
for updating SRs contrasts with substantial developments in other methodological 
areas such as imputation of variance, publication bias, or assessment of 
heterogeneity. Similarly, more work has been devoted to the development and 
evaluation of the methodology for updating CPGs than for SRs [7].  
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There has been little evidence or guidance which would indicate what proportion of 
SRs are in need of updating, when to initiate an update, and how best to implement it 
[14]. Organisation such as Cochrane have a policy of updating their SRs every two 
years [5]. Although Cochrane have invested substantial efforts in keeping SRs up-to-
date, non-Cochrane SRs, which account for about 80% of all published reviews are 
not usually updated. Specifically, within 2 years of their publication, only 2.3% of 
SRs published in peer-reviewed journals had been updated compared to 37.6% of 
those published by Cochrane groups [22, 7]. Another study showed similar results 
with half of 36 Cochrane reviews (issue 2, 1995) updated compared to only one of 
39 reviews published in paper-based journals and indexed in Medline in 1995 [31]. 
The update rates have been low even among Cochrane reviews. For example, in one 
empirical study of the 101 Cochrane pregnancy and childbirth reviews published in 
issue 3 of 2007, only 32.7% were updated within the 2-year period of its publication 
[27].  
 
There have been multiple underlying barriers to a routine updating of SRs: a) 
absence of definition of what an update constitutes, b) lack or uncertainty as to when 
and how to update, b) high costs and lack of resources or funding, c) logistical 
issues, d) long period of time between the protocol formulation and review 
publication, e) original authors changing their affiliations, and f) original authors’ 
loss of interest or lack of motivation [7, 14, 32-34]. In their study, Henderson and 
colleagues, identified 33 barriers to successful updating of a review [35]. 
 
Up until 2006, there was no formal definition of what constitutes an update of a SR. 
Without a definition, readers may encounter problems in determining if a SR had 
been updated or not. Also, researchers who surveyed updating practices across 
different groups or organisations may have perceived updating processes differently, 
leading to inconsistent assessments of currency of SRs. These differences, in turn, 
could have rendered these studies non-comparable [12]. 
 
Likewise, there has not been a standard methodology to assess the need for updating 
a review at a given point in time [7, 13, 29]. Periodic literature surveillance [36], 
obtaining expert opinion [37], and assessing the need for updating[38-40] help to 
prioritise SR updates which is a an efficient approach. In contrast, updating SRs at 
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arbitrarily defined time intervals is likely to result in inefficient use of resources, as 
reviews from diverse clinical areas have different need for updating depending on 
the pace of developments occurring in a given clinical area [7, 29]. For example, one 
study [30] has empirically shown that for drug CERs, the evolvement of evidence 
(i.e., emergence of new drugs, new safety alerts, and number of new trials) in 
psychiatric topics occurred at a faster pace compared to that in non-psychiatric topics 
such as endocrinology, respiratory, pain, or cardiology (mean number of new 
relevant citations: 38.4 vs. 8.2, p=0.012). The authors also identified that significant 
predictors for updating were the numbers of new relevant trials (OR=1.06, 95% CI: 
1.03, 1.10) and new drugs (OR=5.71, 95% CI: 1.68, 19.44) [30].     
 
1.4. Introduction to published work  
In order to address the above-mentioned gaps and methodological challenges of 
updating SRs, the author of this dissertation and his colleagues conducted and 
published three methodological empirical studies (Publications 2, 3, 4, and 6) and 
two non-empirical conceptual works (Publications 1 and 5) presented in 6 peer-
reviewed publications, which are included in this thesis (Appendices 1-5) [12, 7, 41, 
13, 14, 38]. Publication 1 [12] proposed the first formal definition of what 
constitutes an update of a SR. The article presented distinguishing features of an 
updated vs. not updated or a new review. Publication 2 (or Publication 3; Study #1) 
[7, 41] is a SR of methods and strategies describing when and how to update SRs. 
Publication 4 (Study #2) [13], an international survey, identified and described 
updating practices and policies of organisations involved in the production and 
commission of SRs. Publication 5 [14], reviewed the knowledge and efforts in 
updating SRs and provided consensus-based guidance for authors and institutions 
conducting SRs as to when and how to update comparative effectiveness reviews 
(CERs) produced by the AHRQ’s Evidence-based Practice Centers (EPCs) 
throughout North America [42]. Publication 6 (Study #3) [38] describes the 
development and piloting of a surveillance system (consisting of limited literature 
search, identification of qualitative and quantitative signals triggering updating, and 
expert opinion) to assess the need for updating CERs produced by the AHRQ’s EPC 
Program [42].   
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2. What is an Update of a Systematic Review  
Publication 1 (Appendix 1) – Systematic Reviews: When is an Update an 
Update? [12] 
 
2.1. Introduction and rationale 
In this publication, we proposed the first formal definition of what constitutes an 
update of a SR. We acknowledged that the lack of a formal definition for updating 
would lead to inconsistent conceptualization of what an update of a SR is or whether 
or not any given review has been updated. Moreover, researchers surveying updating 
practices across relevant agencies or examining overviews reporting on updating 
status of included SRs could perceive and qualify these processes differently, thereby 
rendering the current and future research studies non-comparable.       
 
2.2. Definition of an update of systematic review   
We believe that the introduction of a formal definition and explanation for updating a 
SR is long overdue. The definition of “to update” means “to extend up to the present 
time” or “to include the latest information”. We defined an update of a SR as a 
discrete event with the aim to search for and identify new evidence to incorporate 
into a previously completed SR.  
 
The central and necessary element of an update is the effort to identify new 
evidence. The term “new evidence” in this context is used broadly—evidence that 
has not been included in the previously completed review. For example, the authors 
consider updating takes place when a search strategy of the original review is applied 
to an additional (not searched previously) database to identify any evidence not 
previously incorporated. Alternatively, updating could be initiated after a specific 
period of time has elapsed since the completion of the original SR, which allows for 
the identification of new evidence that has emerged during this time. We note that 
even if a search does not identify any new relevant evidence, this event still 
constitutes an update. In other words, to undertake an updating process, a systematic 
search needs to be initiated with the purpose of determining whether or not new 
evidence exists.  
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In an update, the most of the originally formulated protocol (e.g., eligibility criteria, 
search strategy) is retained, or some parts of it are extended to accommodate newly 
identified evidence (e.g., new subpopulation, new type of treatment or outcome).  
We do not consider an update a re-analysis or replication of the original SR using a 
new or modified method (e.g., statistical pooling, risk of bias tool) without initiating 
a new search.  The use of a new search terminology without an effort to identify new 
evidence would not be regarded an update either. Corrections of mistakes, errors, or 
typographic errors detected in a previously completed SR would not constitute an 
update, since these operations do not allow the identification of any new evidence.   
 
2.3. Key messages and significance of Publication 1 
The consistent definition, conceptualisation, and use of updating context across 
research community is an important step towards international harmonisation of 
updating SRs.  
 
This paper is published in the Lancet. The Lancet is one of the highest impact factor 
biomedical journals across the globe (45.217). It belongs to the General and Internal 
Medicine category. In this category which includes a total of 154 journals, the 
Lancet ranks as the 2nd (Q1 quartile).  
 
A high number of citations for this publication (Scopus index: 54; on 2nd December, 
2016) is indicative of a high uptake and wide use of the definition by the 
international scientific community. The definition proposed in this publication has 
been adopted and used by Cochrane and is included in the Cochrane Handbook for 
Systematic Reviews of Interventions [5]. Moreover, the paper has been cited by the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guideline. The journals citing this publication cover a wide number of different 
subject areas such as general medicine (Ann Intern Med, Nature Medicine, BMJ, 
PLoS ONE, PLoS Medicine), specialist clinical (Br J Psychiatry, Hypertension, 
Blood Press), methodology (Stat Methods Med Res, J Clin Epidemiol, Syst Rev, 
Biom J), alternative/complementary medicine (J Altern Complement Med, Phys 
Ther), nursing (Nursing Outlook), and public health (Health Policy). 
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3. When and How to Update Systematic Reviews 
Publication 2 (Appendix 2) - A Systematic Review Identified Few 
Methods and Strategies Describing When and How to Update Systematic 
Reviews [7]   
 
Publication 3 (Appendix 2) - When and How to Update Systematic 
Reviews [41]  
 
Information below is presented according to Publication 2. 
 
3.1. Introduction and study rationale  
Although updating SRs may yield important additional information, this process can 
be as costly and time consuming as conducting a new review. The decision when to 
update a SR depends on several factors: a) rapidity and scope of scientific 
developments, b) nature of the health condition, and c) public health importance of 
the health condition. We conducted a SR of strategies and methodologies describing 
when and how to update SRs. The aim was to identify, synthesise, and characterise 
these approaches in terms of their strengths, limitations, and applicability. 
 
3.2. Methods  
We searched Medline (1966 to December 2005), PsycINFO (1955 to June, Week 1, 
2005), and the Cochrane Methodology Register (CMR) (Cochrane Library Issue 1, 
2006). The reference lists of potentially relevant reports were scanned. The 
proceedings of the 13th Cochrane Colloquium (August 2005) were also hand-
searched. The searches were not restricted by language, publication type, or study 
design. Three investigators independently screened titles, abstracts, and full-text 
reports of all the retrieved bibliographic records. I and another reviewer 
independently extracted relevant data using a pre-piloted 15-item extraction form. 
Disagreements at the screening and extraction phases were resolved by discussions.  
 
Included approaches for updating SRs were grouped as strategies, techniques, and 
statistical methods. The strengths and limitations for each approach were determined 
through a consensus-based judgment reached by the review authors.  The approaches 
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were described in terms of when and how to update, comprehensiveness (e.g., 
covering clinical, statistical, or other domains), strengths, and limitations.   
 
3.3. Results 
Fifteen publications (four strategies, one technique, and two statistical methods) 
describing when and/or how to update SRs were included in the review (Table 1)   
[7].  
 
Strategies and techniques for updating SRs 
The first strategy (Steps in maintaining an updated review) describes the process of 
maintaining updated SRs of randomised controlled trials (RCTs) evaluating the 
effects of perinatal care.  
 
The second - Cochrane strategy (Maintaining an updated review) is based on the 
two-year recommended interval for an update to occur after the publication or 
completion of the review. If a review is updated less frequently than once in two 
years, the Cochrane requires that reviewers provide a commentary explaining the 
reasons why.  
 
The third strategy (Assessment of need to update) proposed by the Cochrane 
Infectious Disease Group involves two steps and follows the two-year cycle updating 
policy. The first step is to assess whether a review is up to date by considering its 
age, availability of new relevant trials, and the number of participants in the new 
trials. The second step is to assess the importance of the topic through ascertaining 
the burden of disease and pace of development of the field. Both steps involve 
judgment decisions reached by an editorial consensus. This strategy assists in 
assigning an order of priority to reviews in need of updating.  
 
The fourth strategy provides a guidance as to when and how to update SR or HTA. 
When conducting an update, the strategy suggests considering clinical endpoints, 
treatment characteristics, statistical methodology, public health impact of treatments, 
and the availability of resources. 
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Techniques for updating SRs 
It is important that database searches performed for updating SRs retrieve all 
relevant records. Bergerhoff suggested that reviewers use the ‘‘entry date’’ field 
rather than the publication year when performing updating searches for SRs. This 
search results in a more complete retrieval of relevant records including those that 
have become available since the date of the last search.                                                                                                                                                                                                                                                                                                                                                                                                        
 
Table 1.  Strategies, techniques, and statistical methods for updating systematic 
reviews 
Strategy or technique 
(author year; reference 
#) country 
Domains 
covereda 
Strengths Limitations 
Steps in maintaining an 
updated review 
(Chalmers 1993; #14b) 
The UK 
Search strategy, 
administrative 
issues 
 
a) Minimizes publication 
bias by obtaining grey 
literature and contacting 
authors for further 
information, clarifications 
a) Inefficient, b) 
cumbersome to implement 
Maintaining an updated 
review (Cochrane 
Handbook for systematic 
reviews of interventions 
2005; #15) International 
 
Search strategy, 
administrative 
issues, clinical, 
updating format 
a) Periodic updating 
ensures validity at some 
time, b) timing is known 
(e.g., every two years) 
 
a) Inefficient, b) two-year 
updating cycle may lead to 
outdatedness in rapidly 
developing fields or wasted 
resources in slowly 
developing fields 
Assessment of need to 
update (Lutje 2005; #17) 
The UK 
 
Search strategy, 
administrative 
issues, clinical, 
public health 
a) Assesses the need to 
update, b) prioritises 
reviews requiring 
updating, c) efficient 
d) evidence-based editorial 
consensus on whether or 
not to update, e) algorithm 
of administrative actions 
a) Unclear how to 
determine whether a 
review is out of date, b) 
unclear how to determine 
the importance of the topic 
in order to reach editorial 
consensus 
Strategies for updating a 
review (Weller 1998; 
#18) Australia 
Clinical, public 
health, 
economic, 
updating format 
a) Applicable to systematic 
reviews, CPGs, and health 
technology assessments 
a) General description of 
actions, b) low practical 
utility 
Searching using the 
‘‘entry date’’ field 
(Bergerhoff 2004; #19) 
Germany 
Search strategy a) Compensates for 
indexing lag by retrieving 
records indexed since the 
last search regardless of 
publication date 
a) It may not retrieve non-
English records or those 
without abstracts 
Statistical method  
(author year, reference #) country 
Strengths Limitations 
Identifying ‘‘null’’ meta-analyses that are 
ripe for updating (Barrowman 2003; #20) 
Canada 
 
a) Relatively efficient, b) 
easy to use/compute 
formula, c) reduced type I 
error relative to 
conventional CMA, d) test 
sensitivity/specificity 
easily modifiable 
 
a) Applicability limited to 
statistically non-significant 
MA, b) assumes no secular 
trend in effect and that the 
variance of pooled 
estimate shrinks at a rate 
inversely proportional to 
the total number of 
participants in all studies, 
c) test results are sensitive 
to studies’ sizes 
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Conventional CMA (Lau 1992, Lau 1995, 
Baum 1981, Berkey 1996; #21,#22,#23,#24) 
The USA 
 
a) Defines the earliest time 
at which an intervention 
can be shown to be 
efficacious, non-inferior, 
or harmful, b) monitors the 
effect size and direction 
over time, c) timing for 
each update is known, d) 
ascertains the contribution 
of individual studies to the 
cumulatively pooled effect 
estimate, e) allows one to 
explore heterogeneity and 
perform sensitivity 
analysis, f) provides up-to-
date information, g) useful 
in stopping ongoing trials 
or planning future trials 
a) Inefficient if an update 
is conducted every time a 
new study becomes 
available, b) inflated type I 
error due to multiple 
testing, c) affected by 
publication bias 
CMA using the cumulative slope as an 
indicator of stability; CMA for sufficiency 
and stability (Mullen 2001; #25) 
The USA 
a)-g) of ‘conventional 
CMA,’ h) explores the 
stability of the effect size 
and informs the need for 
updating 
 
a)-c) of ‘Conventional 
CMA,’ d) judging extent 
of stability is arbitrary, e) 
variance of the ‘cumulative 
slope is invalid, f) 
minimum size of a meta-
analytic database for fitting 
a regression line whose 
slope would be a valid 
indicator of (in)stability of 
effect not specified 
CMA using sequential monitoring 
boundaries (Pogue 1997; #26) Canada 
 
a)-g) of ‘Conventional 
CMA,’ h) controls type I 
error by using sequential 
monitoring boundaries 
 
a)-c) of ‘Conventional 
CMA,’ d) requires prior 
calculation of the OIS, e) 
does not account for 
heterogeneity or bias 
among studies 
Recursive CMA (Ioannidis 1999, Ioannidis 
2001; #11,#27) The USA 
 
 
a)-g) of ‘Conventional 
CMA,’ h) incorporates 
results from unpublished 
studies and follow-up or 
more detailed data for 
studies already included in 
the CMA, i) documents the 
evolution of results as 
missing, updated, and new 
data are incorporated in 
information steps, j) 
evaluates updated follow-
up information, 
publication bias or lag, and 
heterogeneity, k) treatment 
effect estimates are based 
on relatively accurate and 
complete data 
a) and b) of ‘Conventional 
CMA,’ c) unpublished and 
updated information must 
be carefully studied and 
verified to minimize bias, 
d) analysis of updated 
follow-up data may 
sometimes be 
inappropriate because 
many post-study patients 
will cross over, e) more 
costly and resource 
consuming than 
conventional CMA 
MA=meta-analysis; CMA=cumulative meta-analysis; OIS=optimal information size; CPGs=clinical 
practice guideline(s) 
a Domains: search strategy, statistical method/technique, clinical (expert opinion, long/short–term outcomes, 
intervention, pace of development in the field, nature of condition), public health importance (severity of 
condition and prevalence), economical (e.g., resource availability), updating format (preference for electronic vs. 
paper-based format; information steps), and administrative issues (e.g., those related to the implementation of 
updating process of systematic reviews).  
b Reference #s refer to those in the original publication (Publication 2, Appendix 2) 
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Statistical methods for updating SRs 
Barrowman and colleagues [43] proposed a diagnostic test, which helps to assess if 
an additional new evidence may have been accrued which would be sufficient to turn 
a statistically non-significant result of a meta-analysis (MA) into a significant one, 
thereby rendering it in need of updating. Computer simulations indicated that the 
diagnostic test identified whether a MA was out of date with a sensitivity between 
49% and 62% and a specificity between 80% and 90%, depending on the 
configuration of the simulation. This method predicts the appropriate timing for an 
update, requiring the conduct of search, screening, and only partial data extraction 
(e.g., number of additional participants), rather than spending considerable resources. 
The application of this method is limited to MA with a statistically non-significant 
result under the assumption that this may have been due to insufficient power.  
 
The cumulative meta-analysis (CMA) [44] is a statistical procedure in which the 
combined effect estimate is sequentially updated by incorporating results from each 
newly available study. It documents trends in a treatment effect over time and 
provides clinicians and policy makers with up-to-date information. When done 
prospectively, CMA may identify the earliest time at which there is sufficient 
statistical evidence that an intervention is non-inferior, efficacious, or harmful, 
thereby serving as a signal to stop trials that are under way earlier than planned (or at 
least not to initiate any new ones) because of ethical concerns and economic 
implications. The use of CMA is a costly and cumbersome process, which is prone 
to lead to an inflated type I error rate due to repeated hypothesis testing. This 
limitation necessitates the adjustment of the alpha level of statistical significance 
[45]. For application to updating MA, CMA use has three extensions: a) cumulative 
slope as an indicator of stability (CMA for sufficiency and stability) [46], b) 
sequential monitoring boundaries [47], and c) recursive CMA [48].  
 
3.4. Key messages and significance of Publication 2 (or Publication 3) 
Because health care evidence continually evolves as new research becomes 
available, SRs need to be kept up-to-date. Ignoring new information may undermine 
the validity of not only SRs but also CPGs. Up to now, methods used for updating 
SRs in health care have not been systematically reviewed.  
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In general, the identified strategies and one technique do not include quantitative 
techniques, are arbitrary in nature, may be inefficient, are limited in applicability, 
and are not sufficiently comprehensive in terms of domains addressed. The 
effectiveness of these approaches is unclear because they have not been empirically 
tested or compared to one another. CMA and its methodological extensions are 
resource-consuming approaches for updating SRs. Although the method by 
Barrowman is less resource-intensive than CMA, it is strictly a statistical approach 
with limited application to only MA with statistically nonsignificant results.  
 
The relative paucity of well-elaborated methods for updating SRs contrasts with 
developments in methods for updating CPGs as well as other methodological areas 
of conducting SRs (e.g., publication bias, heterogeneity). The findings of this review 
suggest that the importance of updating SRs has not been well recognized, and that 
considerably more investment should be made to investigate this construct. The 
development of adequate and cost-effective methodologies for updating SRs would 
be an important step toward maintaining SRs up to date. Additional efficiency may 
be gained with international harmonization of aspects of the updating process.  
 
The author of this commentary intends on updating this SR to reflect methodological   
developments that have taken place in the past decade since the publication of this 
review. The updated review is expected to identify new checklists, statistical tools, 
multi-dimensional methods as well as economic decision tools guiding the updating 
process of SRs. Moreover, newly accrued empirical evidence on the longevity of 
SRs (until their conclusions are still valid) will inform the most optimal time when to 
update any given review. Ideally, the scope of this update should extend to 
unpublished methods for updating SRs as well as methods for updating CPGs. 
 
This paper (Publication 2) is published in the Journal of Clinical Epidemiology. This 
journal is one of a higher impact factor biomedical methods journals (3.417). It 
belongs to two categories: 1) Health Care Sciences and Services and 2) Public, 
Environmental, and Occupational Health. In the first category, which includes a total 
of 88 journals, the Journal of Clinical Epidemiology ranks as the 10th (Q1 quartile). 
In the second category (165 journals), this rank is the 22nd (Q1 quartile). 
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This article has been cited 45 times since its publication in 2007 (in Scopus; 2nd 
December, 2016). The citing sources are the Cochrane Handbook for Systematic 
Reviews of Interventions [5] and multiple journals covering a wide array of subject 
areas such as general medicine (Ann Intern Med, BMJ, PLoS ONE, J Evid Based 
Med), specialist clinical (Eur J Orthod, Kidney Int, BMC Pediatrics, J Pain Symptom 
Manage, Psychiatr Serv), methodology (J Clin Epidemiol), and education (Med 
Teach, Patient Educ Couns).  
 
The same study was also published by Cochrane (Publication 3)[41] and since its 
publication in 2008, it has been cited 52 times (in Scopus; 2nd December, 2016).  
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4. Updating Practices and Policies: International Perspective 
Publication 4 (Appendix 3) - Updating Systematic Reviews: An 
International Survey [13] 
 
4.1. Introduction and study rationale 
It is not clear what are the updating policies and practices of organisations that 
commission or produce SRs. We conducted an international survey to describe the 
updating policies and procedures used by healthcare organisations producing and/or 
sponsoring SRs worldwide. 
 
4.2.  Methods 
The survey consisted of 48 questions (including skip-logic functionality) covering 
the following topics: a) updating policies, b) responsibility for updating, c) changes 
in estimates of outdated reviews, d) updating approaches (e.g., when/how to update, 
surveillance, and triggers impacting updating decisions), e) barriers and facilitators 
to the updating process, f) views on harmonization of updating, and g) descriptive 
characteristics of the organisation and the representative key informant. The survey 
was provided to participants via the Survey Monkey web-based service 
(www.surveymonkey.com). The main survey was administered between 12 April 
and 8 June, 2007 with reminders emailed at one, three, and six weeks from the first 
point of contact.  
 
A purposeful non-random sampling approach was used to sample organisations 
involved in undertaking or funding SRs. The sample was expended by including 
entities dealing with HTAs and CPGs. In addition, 52 Cochrane Review Groups 
(CRGs) were invited to participate in the survey. The final sampling frame consisted 
of 195 different organisations. Closed-ended questions were analysed using a 
descriptive summary of findings in the form of frequencies and percentages. A 
subgroup analysis was performed comparing Cochrane groups to non-Cochrane 
organisations for their responses across select updating characteristics. Survey 
findings were analysed using descriptive statistics. 
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4.3.  Results 
The initial survey response rate was 65% (127/195), of whom 10% (13/127) declined 
participation, leaving 58% of responders (114/195) who completed the survey. 
Thirty percent of all organisations (34/114) were CRGs. The 114 participating 
organisations were from 26 countries with the UK, the US, Canada, and Australia 
accounting for 62% (71/114) of the sample. About 70% (75/107) of the organisations 
were producers of SRs, 5% (5/107) were funders only, and 25% (27/107) were both 
funders and producers. Ninety-six percent (96/100) of the responders were not-for-
profit agencies, with 40% of them being academic institutions and 21% National 
Government agencies. Eighty-five percent of funding was accounted for by 
Government research or infrastructure grants. While 20% (23/114) of the 
organisations reported to have been involved in the production or commission of 
SRs only, only 46% (52/114) of them reported a wider range of involvement 
including SRs, HTAs, and CPGs.   
 
Approximately 96% (103/107) of the respondents agreed ‘strongly’ or ‘somewhat’ 
with our definition of updating [12]. About 80% of the organisations (84/107) 
viewed the importance of updating SRs as ‘high’ or ‘very high’. Of the respondent 
organisations, 57% (60/106) indicated having an updating policy, of whom only 29% 
(35/106) made reference to a written policy (29 of the 35 were CRGs).  
 
About one-third of all respondent organisations (35/105) reported regular, whereas 
59% (62/105) reported irregular updating practices. Approximately, 8% (8/105) of 
the organisations had not reportedly engaged in updating practices. Sixty-three 
percent (66/105) of the organisations reported to have conducted regular literature 
searches to identify new evidence, while 28% (29/105) reported no such activity. 
The most frequently used approach for updating SRs was based on a pre-set time 
frequency (66/99; 67%).  
 
About half of the organisations (53/103) deemed that over 50% of their SRs were 
out-of-date. Authors of the original SRs (42/106; 40%) were most often considered 
responsible for ensuring the currency of SRs. About 16% of respondents thought that 
responsibility for updating was a collective effort shared among review authors, 
funders, information specialists, and policy-makers. The most influential predictors 
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for updating were formal request from a policy/healthcare decision maker (80/99; 
81%), number of new studies identified (77/100; 77%), totality of all new evidence 
including benefits and harms (75/99; 76%), and emergence of new serious adverse 
event (74/100; 74%). Barriers to updating included resource constraints and limited 
funding (72/100; 72%), reviewer motivation (53/96; 55%), limited academic credit 
(49/100; 49%), and limited publishing formats (35/100; 35%). The majority of the 
respondents (70/100; 70%) indicated some support for centralised updating efforts 
across institutions or agencies that produce SRs. The most commonly perceived 
benefits of international harmonization efforts for updating were a more efficient use 
of existing resources (79/101; 78%) and access to new information, ideas, materials 
or other resources (79/101; 78%). 
 
There were significant differences between CRGs and non-Cochrane organisations 
across certain updating characteristics: more CRGs than non-CRGs described their 
general updating practices as regular (31.8%, 95% CI: 11.40, 48.9), viewed authors 
as most responsible for updating (59.6%, 95% CI: 39.1, 72.1), and conducted regular 
literature searches to monitor the literature (23.5%, 95% CI: 4.3, 38.6).  
 
4.4. Key messages and significance of Publication 4 
We believe that this was the first survey to examine updating practices of 
organisations engaged in knowledge synthesis. It was guided by a conceptual 
framework, had a good response rate, and included strong international 
representation.  
 
This survey revealed inconsistencies between the belief of the importance of 
updating and the limited updating activity among respondents outside Cochrane 
(nearly 70% of the respondents). Analysis of CRGs and non-Cochrane organisations 
showed several significant differences in approaches to updating. Most fundamental 
is the Cochrane’s policy recommending the 2-year interval for an update (after 
publication or last update) and authors’ agreement to keep reviews up-to-date. Not 
surprisingly, the CRGs perform updates in greater numbers than other respondent 
organisations. Within Cochrane, responsibility for updating resides predominantly 
with the authors. This did yield an advantage in that CRGs were able to draw on the 
same review team for updating to a greater extent than non-Cochrane respondents. 
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Still, when reviewers had responsibility for updating, reviewer motivation was the 
most prominent barrier to updating.  
 
Placing the duty for updating mainly on authors of SRs has had some success within 
Cochrane although this may not be a practical approach for agencies that do not 
share its values and culture. Journal publishers and academic organisations can 
contribute to overcoming some of the known motivational challenges faced by 
authors with updating duties. Academic institutions can support updating by 
according academic recognition on par with conducting and publishing original 
reviews. Journals can increase publishing outlets for updates, for instance, when 
accepting a review for publication, by also committing to publishing any future 
updates. Organizations can make updates more prominent by tying them to the 
original review.   
 
This survey was of descriptive nature, more appropriate for generating rather than 
testing a specific hypothesis. Some of the main limitations of this survey were its 
non-random sampling frame and the low participation rate (58%). Selection bias may 
have been introduced if participants (i.e., responders) of this survey were 
systematically different from non-participants in their characteristics that were 
associated with their responses. 
 
This paper is published in the PLoS One. This journal’s impact factor is 3.234. It 
belongs to the Multidisciplinary Sciences category, which includes a total of 57 
journals. PLoS One ranks as the 9th in this category (Q1 quartile). 
 
This article has been cited 24 times since its publication in 2010 (in Scopus; 2nd 
December, 2016). The citing sources are multiple journals covering a wide array of 
subject areas such as general medicine (J Comp Eff Res, Science, BMJ, PLoS ONE), 
specialist clinical (Genet Med, Eur J Orthod, BMC Dermatol, BMC Pulm Med), and 
methodology (J Clin Epidemiol, Med Decis Making).  
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5. Guidelines for Updating Comparative Effectiveness Reviews 
Publication 5 (Appendix 4) - Updating Comparative Effectiveness 
Reviews: Current Efforts in AHRQ’s Effective Health Care Program 
[14]  
 
5.1. Introduction and rationale  
To maintain relevance, SRs need to be updated as new evidence is produced [15, 
16]. The lack of attention to updating may lead to evidence-based conclusions 
becoming outdated and sometimes misleading, thus compromising health care and 
policy decisions. These problems could lead to a waste of resources, provision of 
redundant or ineffective health care, failure to implement more effective health care, 
and possibly cause harm. Disseminating the updated reviews will increase the 
awareness of new findings among relevant stakeholders and the likelihood that new 
evidence is incorporated into clinical practice. 
 
The AHRQ, like other large organisations producing evidence synthesis reports (e.g., 
Cochrane, NICE, CADTH), have faced a dilemma in relation to keeping their 
evidence synthesis research up-to-date. An important cornerstone of AHRQ’s 
research is the Effective Health Care (EHC) program of which one of its mandates is 
to produce Comparative Effectiveness Reviews (CERs). A CER is a type of SR that 
synthesizes the available scientific evidence on a specific topic, beyond the 
effectiveness of a single intervention, by comparing the relative benefits and harms 
among a range of available health interventions for a given condition [42]. In this 
article, we report the current efforts and consensus-based guidance on updating SRs 
as applied to CERs.  
 
5.2. When to update comparative effectiveness reviews 
There has been a lack of knowledge and methodological uncertainty as to when any 
given SR needs to be updated [7]. Certain signals may trigger an update of a CER at 
any given time (e.g., results from newly published studies, newly emerged 
interventions or outcomes, devices, diagnostic tests). The optimal timing for 
updating a CER depends on the rapidity of scientific developments in a given 
clinical area as well as the nature and public health importance of the health 
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condition in question. Conducting periodic literature surveillance[36], obtaining 
expert opinion[49, 50, 37], with the application of quantitative and qualitative 
signals indicating the need for updating [24] are helpful sources for efficiently 
determining when to update a SR. Although surveillance search strategies typically 
are not comprehensive, they are useful in flagging CERs in need of updating. For 
example, Sampson and her colleagues [36] compared the performance of five 
different surveillance search techniques (i.e., related articles, clinical queries, 
CENTRAL, core clinical journals, and citing article) for identifying relevant new 
evidence needed for updating 77 SRs. The combination of the PubMed-related 
articles search and subject searching with clinical queries was the most effective 
approach.   
 
Identifying new evidence on harms warrants at least the same rigor in surveillance 
search as that for benefits; it should be an integral part of the updating process. Drug 
warnings often based on adverse events data reported by consumers or medical 
providers can be found in nationally licensed databases (e.g., US Food and Drug 
Administration/FDA). Since such data are not routinely submitted for journal 
publication, it is recommended that during an update, peer-reviewed literature 
searches be supplemented by searches of specific repository sources of adverse 
events (e.g., the US FDA’s Safety Information and Adverse Event Reporting 
System, the UK’s Medicines and Health Care Products Regulatory Agency, Health 
Canada) [51].  
 
Experts in the field are often aware of new developments before they become public 
(e.g., new drugs or devices, ongoing trials, articles in press, safety alerts). Expert 
opinion has been used in updating clinical practice guidelines [49, 50]. While 
reviewers are updating a CER, they may find expert opinion useful as a supplemental 
source for new evidence [52]. The experts may be asked of their opinion if the 
conclusion of any given review is still valid and whether or not they are aware of any 
new evidence that may change this conclusion [37]. 
 
Shojania and colleagues [24] proposed quantitative and qualitative signals indicating 
when a SR needs an update (the Ottawa method). They defined a quantitative signal 
as a change in the statistical significance for an effect estimate (at α=0.05) or a 
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relative change of ≥50% in the magnitude of an effect. The authors defined a 
qualitative signal as a qualitatively different characterization of effectiveness that 
influences clinical decision making (e.g., a new harm, a new alternative therapy, or a 
treatment expanded to a new patient subgroup).  
 
5.3. How to update comparative effectiveness reviews 
If new studies are published, new harms have emerged, or a new and more effective 
intervention(s) is introduced, the question of ‘when to update’ becomes ‘how to 
update’.  
 
Scope of updating considering key research questions and PICO framework 
The updating process can be viewed as a continuum over a wide range of activities 
from a single update search (e.g., yielding no new evidence) to a comprehensive 
search leading to the incorporation of new evidence. Therefore, the rational choice of 
the scope for an update search will depend largely on where a given investigator 
stands along the continuum of updating process and available resources allocated to 
updating. The assessment process of the updating scope and corresponding 
modifications are depicted in Table 2. 
 
Because medical disciplines are constantly evolving through emergence of new 
evidence, it is recommended that reviewers assess all key questions (KQs) of the 
original CER at the initial stage of updating. Specifically, they should determine the 
extent to which the constituent elements of the key research question(s) denoting 
Population, Intervention, Comparator, and Outcome (PICO) may have changed. If an 
update search does not identify any relevant evidence, the CER will not be modified. 
However, the status of the CER will be labelled as ‘updated’ by including 
information on the search dates and time periods covered by the search. When newly 
identified evidence does not entail the modification of any PICO elements of a KQ 
(e.g., no new population, intervention, or outcome identified), the update process 
will consist of only incorporating this evidence into relevant sections of the report 
(e.g., Results and Conclusion).  
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Table 2. Scope of updating and corresponding actions  
Newly identified evidence  Action for updating a CER 
Search performed but no new 
studies identified 
 No action 
 Mark as ‘updated’ 
 Provide search sources, dates, period 
Search performed and new studies 
identified (without identification of 
a new PICO element) 
 Update Results and/or Conclusion sections  
 Mark as ‘updated’ 
 Provide search sources, dates, period 
New evidence from already 
included 
studies (without identification of a 
new PICO element) 
 Update Results and/or Conclusion sections  
 Mark as ‘updated’ 
 Provide search sources, dates, period 
Search performed, new study or 
studies with one or more new PICO 
element identified: 
 New (sub)population(s) 
 New intervention(s)  
 New comparator(s)  
 New outcome(s) 
 Extend the inclusion/exclusion criteria for 
corresponding PICO element to accommodate the 
incorporation of new evidence  
 Update Introduction, Methods, Results, and 
Conclusion sections 
 Mark as ‘updated’ 
 Provide search sources, dates, period 
KQ=key question; PICO=population, intervention, comparator, outcome; CER=comparative effectiveness 
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However, if newly identified evidence includes a new PICO element (e.g., new harm 
and/or new subpopulation was identified), the eligibility criteria has to extend and 
the KQ be modified with respect to the given PICO element to accommodate this 
evidence in relevant sections of the updated CER (e.g., Introduction, Methods, 
Results, and Conclusion). The identification of evidence on the same intervention, 
comparator, and outcome as specified in a KQ of the original CER, but for people 
with a newly identified health condition, would not be an update of the previous 
CER because it entails the exploration of a new KQ. 
 
Evolution of methods when conducting an update 
Methods used to conduct CERs (e.g., methods for pooling, assessing the risk of bias, 
and grading the strength of evidence) continue to evolve over time. If some of these 
methods have changed by the time of an update, we recommend that investigators 
compare the methods used in the original CER with the newly developed methods. If 
the new methodology is an obvious improvement over the older one, the CER team 
should ideally re-review (e.g., appraise and grade) all previously and newly included 
studies using the new methodology for sake of consistency between the original and 
updated review. Moreover, critical feedback obtained on the original review can 
provide useful information regarding correct choices for the analyses the reviewers 
might consider conducting in an updated CER. For example, if a CER is criticized 
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for its use of a fixed-effect over random-effects model for pooling results of 
individual studies, conducting a sensitivity analysis using both pooling methods (or 
only random-effects model, if deemed appropriate) in the update might be 
reasonable.   
 
Incorporating new evidence and reporting an update 
To make updates most useful, reviewers need to describe the purpose and methods 
used for the update.  Reviewers should explicitly note any changes in the scope, 
methods, and results for each KQ in the updated versus original review. The 
rationale for introducing any new methodology or different conceptual framework in 
the updated report also needs to be described.  
 
Important elements to focus on include the search strategy, the yield of the searches, 
important characteristics of new evidence (number, type, size, and quality of studies; 
study participants; and outcomes), and main results, including how the conclusions 
of the update differ from those of the original review. When incorporating evidence 
on a new intervention, outcome, or subpopulation group, we suggest adding a new 
section in the Results chapter of the CER report. 
 
The updating process will have optimal credibility if it is conducted and reported 
transparently. To ensure continued transparency, the EHC program should publish 
the titles of CERs selected for updating. Updated CERs should include a description 
of how they were updated. There should be adequate opportunity provided for public 
comment on both the CERs chosen for updating and subsequent updated draft 
reports. Posting a list of KQs for CERs that will be updated will ensure that a broad 
range of stakeholders have the opportunity to provide relevant new evidence that the 
project team might consider as informative to the decision-making process. 
 
Issues of authorship and challenges of updating CER 
Ideally, the original CER authors should be asked to conduct an update. But this 
approach may problematic because authors may be working on new topics, may 
have changed institutions or affiliations, or may not be interested in updating the 
already published CER. According to Garritty and colleagues [13], only half of the 
surveyed organisations involved in evidence synthesis were able to draw on the same 
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authors of the original review for updating. This phenomenon poses significant 
problems for the cost, time, and practicality of an update. Naturally, new reviewers 
would require additional time to become familiar with a CER. In addition, 
knowledge of project history would be diminished or perhaps lost, and issues of 
replication and transparency could arise if the original CER was not well reported. 
These factors combined would add to costs and jeopardize the feasibility of 
updating. 
 
If an update involves new authors, it is important to discuss the author issues as early 
in the updating process as possible. One objective would be to ascertain the level of 
involvement and authorship of the original CER team in the update. These 
discussions can be informed by examining current international policies and 
guidance on authorship suggested by the International Committee of Medical Journal 
Editors (www.icmje.org) and contributions of authors [53]. 
 
5.4. Current and future research efforts 
In the near future, a standardized guideline for updating CERs applicable across 
EPCs covering a range of health care interventions and treatment modalities is 
needed. This guideline could incorporate a stepwise use of selected updating 
strategies and methods that have been empirically shown as valid, reliable, and 
resource efficient. Ideally, such a guideline would include specific recommendations 
on three important dimensions: (a) setting updating priorities based on factors such 
as public health burden, severity of health condition, qualitative/quantitative 
updating signals, number of outdated KQs for a given CER, (b) clarifying the 
responsibilities and authorship (especially when authors of the original report change 
their institutional affiliations or are difficult to locate) for updating CERs, and (c) 
implementing the updating process (by considering (a) and (b)). 
 
5.5. Key messages and significance of Publication 5  
In the absence of empirically validated methods for updating SRs, this guidance 
article is an early attempt to help interested authors and organisations in keeping 
their CERs or SRs current. This document provides an initial framework for 
consistent conceptualisation and application of updating processes across individual 
scientists and organisations.      
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This paper was published in the Journal of Clinical Epidemiology. This journal is 
one of a higher impact factor biomedical methods journals (3.417). It belongs to two 
categories: 1) Health Care Sciences and Services and 2) Public, Environmental, and 
Occupational Health. In the first category, which includes a total of 88 journals, the 
Journal of Clinical Epidemiology ranks as the 10th (Q1 quartile). In the second 
category (165 journals), this rank is the 22nd (Q1 quartile). 
 
This article has been cited 12 times since its publication in 2011 (in Scopus; 2nd 
December, 2016). The citing sources are journals covering areas of general medicine 
(J Gen Intern Med, BMJ), specialist clinical (Pain Physician), methodology (J Clin 
Epidemiol) and veterinary medicine (Preventive Veterinary Medicine).   
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6. Assessing the Need for Updating Systematic Reviews 
Publication 6 (Appendix 5) - A surveillance system to assess the need for 
updating systematic reviews [38]  
 
6.1. Introduction and study rationale 
Rapid accumulation of new research findings has raised concern among 
organizations about how best to identify which reviews may be out of date and 
whether to update or simply remove the outdated review from their websites. To 
date, organizations and initiatives (e.g., Cochrane, DERP) have relied on time-based 
periodic updating policies that have proven to be problematic in terms of feasibility 
and efficiency [13, 14, 29, 40, 30]. The previous research demonstrated that reviews 
become obsolete at different rates [30, 29, 24], suggesting that a system of regular 
surveillance might be a more effective way of identifying potentially out-of-date 
reviews. 
 
In order to build upon the previous research and address the above-mentioned 
limitations, the AHRQ supported the development of a regular surveillance system 
for assessing the need of updating all CERs under the agency’s portfolio. This 
section describes the methodology and results of this monitoring system applied to 
24 AHRQ-conducted CERs from June 2011 to November 2012 [38, 54]. 
 
6.2. Methods 
Two EPCs of Southern California (the RAND, the USA) and the University of 
Ottawa (Canada) have jointly started piloting two methods (‘the RAND’ and ‘the 
Ottawa’) for assessing the need of updating of CERs [37, 24]. The RAND method 
relies on the combination of an abbreviated search, clinical expert opinion, safety 
alerts, and determination of the validity of the CER’s individual conclusions (Table 
3) [37]. The Ottawa method ascertains qualitative and quantitative signals in newly 
identified evidence (Table 3) [24]. A formal comparison of the RAND and Ottawa 
methods resulted in similar findings [55, 56]. A third EPC (ECRI institute) assisted 
in obtaining safety alerts.   
 
41 
 
This surveillance system utilised the two methods jointly along with standard review 
process (Figure 1): a) abbreviated electronic searches (using the same strategy 
employed in the original CER, but limited to five general medicine journals and five 
specialty journals specific to the topic of the CER), b) study selection using the same 
criteria as in the original CER, c) data extraction of new evidence deemed relevant to 
the KQs of the original CER, d) identification of pre-specified qualitative and 
quantitative signals for updating, e) acquiring clinical expert opinion regarding the 
validity of conclusions in a CER, and f) identification of safety alerts relevant to the 
CER.  
 
For each included new study, I or another reviewer extracted relevant data on study 
characteristics, participant socio-demographic factors, treatment, and outcome 
characteristics into evidence tables. For each conclusion, we first documented the 
absence or presence of new evidence meeting the pre-defined criteria of signal(s) 
indicating a need for updating (Table 3). We then assessed whether the new 
evidence contributed a qualitative signal (e.g., opposing findings, a superior new 
treatment). 
 
Table 3. Criteria for determining that a conclusion is out-of-date in a systematic 
review (or comparative effectiveness review) 
RAND method  
 
1 
Abbreviated search 
Searches used in the original published CERs, the sources searched limited to five general 
medical journals (Annals of Internal Medicine, BMJ, JAMA, The Lancet, and New England 
Journal of Medicine) and five topic-specific specialty journals (usually the journals that 
contributed the most evidence to the original report. These searches were conducted for a 
time period starting six months prior to the last date covered by the searches for the original 
CER (to minimize the number of relevant studies missed due to delayed publication) up to 
the present  
 
1 
Clinical expert opinion  
We identified and contacted two sets of clinical experts: a) those who had worked on the 
CER in question (e.g., the project lead, clinical lead, members of the technical expert panel, 
and peer reviewers) and b) other clinical experts in the clinical content area who had not 
worked on the CER in question (e.g., local or external subject matter experts). For each CER, 
we created a matrix that included each of the original key questions and a summary of each 
conclusion in the original report. Respondents were asked to provide their opinions on 
whether or not each conclusion was still valid. They were also asked to provide references for 
any new studies they were aware of that might invalidate or otherwise alter the conclusion(s) 
as well as studies that were pertinent to the topic but might not address a particular 
conclusion directly (e.g., studies of newer treatments that may have rendered the original 
treatments out-of-date). The responding experts were offered a small honorarium; reminders 
were sent to experts who did not initially respond 
 
1 
Safety alerts  
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We examined safety and adverse event alerts relevant to each CER. This information was 
collected from the US FDA Safety Information and Adverse Event reporting system 
(MedWatch), the UK’s MHRA, and Health Canada. 
 
1 
 
 
 
2 
 
 
 
 
3 
 
 
 
4 
 
 
 
 
 
 
 
 
1 
 
2 
Indications for the need for an update (per conclusion) – additional file 1 [38] 
Original conclusion is still valid and this portion of the original report does not need 
updating. This conclusion was reached if we found no new evidence or only confirmatory 
evidence and all responding experts assessed the CER conclusion as still valid, we classified 
the CER conclusion as still valid 
Original conclusion is possibly out-of-date and this portion of the original report may need 
updating. This conclusion was reached if we found some new evidence that might change the 
CER conclusion, and/or a minority of responding experts assessed the CER conclusion as 
having new evidence that might change the conclusion, then we classified the CER 
conclusion as possibly out-of-date 
Original conclusion is probably out-of-date and this portion of the original report may need 
updating. This conclusion was reached if we found substantial new evidence that might 
change the CER conclusion, and/or a majority of responding experts assessed the CER 
conclusion as having new evidence that might change the conclusion, then we classified the 
CER conclusion as probably out-of-date 
Original conclusion is out-of-date. This conclusion was reached if we found new evidence 
that rendered the CER conclusion out-of-date or no longer applicable; we classified the CER 
conclusion as out-of-date. Recognizing that our literature searches were limited, we reserved 
this category only for situations where a limited search would produce prima facie evidence 
that a conclusion was out-of-date, such as the withdrawal of a drug or surgical device from 
the market, a black box warning from FDA, and so on 
 
Consideration for assigning the updating priority to a CER  – additional file 1 [38] 
How many conclusions of the CER are up-to-date, possibly out of date, or certainly out of 
date?  
How out of date are conclusions (e.g., consideration of magnitude/direction of changes in 
estimates, potential changes in practice or therapy preference, safety issue including 
withdrawn from the market drugs/black box warning, availability of a new treatment)  
Ottawa method 
 
A1 
 
A2 
 
 
A3 
Qualitative criteria for potentially invalidating signals 
Opposing findings: a pivotal* trial or systematic review (or guidelines) including at least one 
new trial that characterized the treatment in terms opposite to those used earlier 
Substantial harm: a pivotal trial or systematic review (or guidelines) whose results called into 
question the use of the treatment based on evidence of harm or that did not proscribe use 
entirely but did potentially affect clinical decision-making 
A superior new treatment: a pivotal trial or systematic review (or guidelines) whose results 
identified another treatment as significantly superior to the one evaluated in the original 
review, based on efficacy or harm 
 
A4 
A5 
A6 
A7 
Qualitative criteria for signals of major changes 
Important changes in effectiveness short of ‘opposing findings’ 
Clinically important expansion of treatment 
Clinically important caveat 
Opposing findings from discordant MA or non-pivotal trial 
 
B1 
B2 
Quantitative criteria signals of changes in evidence 
A change in statistical significance (from nonsignificant to significant or vice versa) 
A change in relative effect size of at least 50% 
CER=comparative effectiveness review; FDA=Food and Drug Administration; MHRA=Medicines and 
Health Care Products Regulatory Agency; MA=meta-analysis  
*a pivotal trial is defined as trial that is published in one of the top five general medical journals or a trial whose 
sample size is at least triple that of the largest trial in the original systematic review. 
 
The presence of qualitative signal(s) were evaluated through incorporating results 
from a new study into a MA of the original CER (change in statistical significance, 
relative effect size change ≥50%). The information on updating signals, expert 
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opinion, and safety alerts was collated, summarized, and tabulated. Based on the 
evidence collated, we used a set of decision rules (Table 3) and categorized each 
KQ-specific conclusion within a CER as up-to-date, possibly out-of-date, probably 
out-of-date, or out-of-date. Then, using the totality of these characterizations and 
pre-specified criteria (e.g., how many conclusions out-of-date, how out-of-date, 
magnitude of change in effect estimate, black box warning), each CER was assigned 
a high, medium, or low updating priority (Table 3).  
 
The CERs assigned a low or medium priority for updating were re-assessed six 
months later and those assigned a high priority were not reassessed and instead were 
referred for updating by considering the availability of resources and other factors 
when making a final decision (Figure 1).  
 
Figure 1. The process of surveillance assessment of the need for updating 
comparative effectiveness reviews (CERs) 
 
CER=comparative effectiveness review; FDA=Food and Drug Administration; MHRA=Medicines and Health 
Care Products Regulatory Agency; KQ=key question   
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We summarized our findings for each of the CERs in brief mini-reports. These 
reports are now posted on the AHRQ website along with the original CERs to which 
they refer (https://effectivehealthcare.ahrq.gov/). Two examples of these mini-reports 
adapted for this dissertation are provided in Appendix 5. 
 
6.3. Results 
Twenty-four CERs were assessed at least once between June 2011 and November 
2012. The characteristics of these CERs and the corresponding surveillance 
assessments are presented in Publication 5 (Table 2). The number of KQs across 
CERs ranged from three to seven. The median number of included studies in the 
original CERs was 104 (interquartile range: 71 to 124) and the median number of 
newly identified studies relevant to the CERs was 15 (range: 0 to 35). The median 
length of time (in months) that had elapsed between the search conducted for the 
CER and the update surveillance search (search time lapse, STL) was 21 (range: 11 
to 62). The number of experts initially contacted ranged from four to 17, with a 
median response rate of 35%.  
 
Of 24 CERs, two (8%), five (21%), and 17 (71%) were assigned high, medium, and 
low priority for updating, respectively. Although a higher updating priority was 
associated with a longer STL and greater number of new relevant articles, still there 
was a substantial overlap, and no threshold existed for either factor that could 
accurately predict the classification of CERs into updating categories. We identified 
nine safety alerts applicable to 24 CERs. None of the agents, devices, or procedures 
evaluated in the 24 CERs had an FDA black box warning (indicating a significant 
risk of serious or even life-threatening adverse effect) issued during our assessment 
period. In only one case was the updating priority of a CER influenced by a safety 
alert. 
 
6.4. Key messages and significance of Publication 6  
The reviewed evidence suggests that the optimal interval for surveillance is yearly. 
Our results indicate that a small proportion of AHRQ-supported SRs may need 
updating within one to two years of the date of their last search. 
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Optimally timed surveillance for assessing the need of updating individual SRs may 
be a more efficient approach compared to updating them based on a fixed-time 
period, simply because SRs get out-of-date at different rates depending on the pace 
of development in literature, emergence of quantitative and qualitative signals, and 
other factors (e.g., available resources, strength of evidence, healthcare burden, 
nature of the condition). The implementation of the surveillance assessment program 
to determine the currency of published AHRQ-supported SRs was not without 
challenges and limitations which included subjective nature of judgements regarding 
the currency of CERs, differences across reports in the ways conclusions were 
presented, low response rates among clinical experts contacted, and delays in the 
release of the original reports themselves. The assessment of need for updating of 
more complex CERs (with multiple KQs and conclusions) was more cumbersome 
and time-consuming to complete, ranging up to 5 months.  
 
By undertaking periodic evaluation of 24 topically diverse AHRQ-commissioned 
CERs, we established the feasibility of a surveillance system to monitor the currency 
of SRs of a wide range of therapeutic interventions. Following this demonstration, 
the AHRQ’s EPCs have been using the Ottawa-RAND surveillance method for 
assessing the need for updating their CERs in prioritising the updating process across 
the organisation. This methodology is equally applicable to SRs with or without MA. 
Other non-AHRQ organisations may find this methodology useful to use it, since it 
is also applicable to non-AHRQ SRs.  
 
For future research, we recommend: 1) modifying and testing the current 
surveillance methodology to encompass reviews of diagnostic and prognostic 
methods, 2) identifying predictors of a review being out-of-date, and 3) assessment 
of the relationship between the quality or strength of evidence and signal detection.  
 
This paper was published in the Systematic Reviews. Although this journal has been 
established very recently (2011), it has published many influential research papers in 
the field of methodology. The focus of the journal covers many aspects of the design, 
conduct and reporting of SRs. The journal publishes high quality SR products 
including SR protocols, SRs related to a very broad definition of health, rapid 
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reviews, updates of already completed SRs, and methods research related to the 
science of SRs, such as decision modelling. 
 
This article has been cited eight times since its publication in 2013 (in Scopus; 2nd 
December, 2016). The citing sources are journals covering areas of general medicine 
(JAMA), specialist clinical (Eur J Orthod), and methodology (Stat Med, Syst Rev).  
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7. Current and Future Research: Challenges and Perspectives 
7.1. Recent progress in methods for updating systematic reviews 
Three empirical methodologic studies and two conceptual works (presented in six 
publications) overviewed in this essay identified important gaps in knowledge and 
laid a groundwork for more research in the field of updating and keeping SRs 
current. This work is expected to inform future research and policy on updating SRs 
as well as maintaining them up-to-date.  
 
Our formal definition of what constitutes an update of SR (Publication 1)[12] has 
been adopted by Cochrane and the high number of citations is indicative of an 
increasing uptake of this definition by the international scientific community. My 
subsequent collaborative works, both a systematic review of methods and strategies 
used for updating SRs (Publications 2 and 3) [41, 7] and the international survey of 
agencies involved in conduct or commissioning of SRs (Publication 4)[13] 
highlighted the dearth of adequate and efficient methods for updating SRs as well as 
inconsistencies in beliefs on updating and updating practices. My next article 
(Publication 5) provided a general guidance on updating and highlighted the 
challenges of authorship of updating SRs among others [14]. Finally, our 
surveillance study for assessing the need for updating CERs showed that updating 
SRs could be prioritised efficiently, suggesting that priority-based updating may be 
more efficient and feasible than updating of all SRs periodically (Publication 6)[38].  
 
In the past decade, more attention, work, and resources have been devoted to the 
issue of updating. Specifically, more methods informing when (or how frequently) it 
is best to update any given review and empirical results comparing these methods 
have emerged. This is an obvious methodological improvement in terms of efficient 
use and allocation of limited resources compared to the allowance of fixed period(s) 
of time to an update without considering many other factors affecting the need for 
updating (e.g., public health burden, updating qualitative and quantitative signals 
identified, and bibliometric measurements).   
 
For example, Cochrane has initiated important steps towards prioritising the 
updating process. Namely, one of the key milestones of Cochrane’s Strategy 2020 
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(2016 Targets) has been to develop and implement a comprehensive updating 
strategy to ensure that all high priority Cochrane reviews are kept up-to-date. 
Cochrane has worked on the methodology for prioritising their reviews for updating 
as described by the Cochrane Neonatal Review Group [39]. This was followed by 
the development of the Cochrane multicomponent decision tool for prioritising the 
updating of SRs [40]. This tool is more comprehensive compared to those described 
in our previous work (Publication 2) [7], since it incorporates both qualitative and 
quantitative signals needed to be considered when updating SRs. The tool provides a 
structured way of identifying SRs whose conclusions are most prone to change. The 
tool consists of a flow chart with decision-making branches (three steps with 
respective questions): step one (is the clinical question already answered or deemed 
no longer relevant?), step two (are there any new factors relevant to the existing 
review?), and step three (are there new studies?). Reasons for decisions made at each 
step (e.g., don’t update, flag review ‘priority for updating’, update now) should be 
provided.  The Cochrane Airways Group (CAG) piloted the tool’s performance on 
21 [40] and later on 270 CAG reviews, of which 30 were successfully prioritised as 
in need of updating [57].   
 
Most recently, Cochrane has drawn on previous research and experience to develop a 
formal consensus-based guideline and checklist informing when and how to update 
SRs.[58] The statements and issues on updating SRs covered in the Cochrane 
guideline are in line with those highlighted in our previous research published in the 
six articles (e.g., the definition, methods of prioritisation, new SR methods, 
authorship, reporting changes). It is worth noting that the panel for updating 
guidance (PUG) expanded the previous definition of an update of a SR (Publication 
1)[12] as follows: ”a new edition of a published systematic review with changes that 
can include new data, new methods, or new analyses to the previous edition.” In 
Cochrane, the decision regarding when to update any given SR is decentralised, 
meaning that it is delegated to the CRG. This is in contrast with the AHRQ where 
this decision is centralised and the prioritisation of CER updates is based on the 
surveillance assessments of the need for updating, as described in one of our six 
publications (Publication 6)[38]. The Cochrane decision algorithm for updating SRs 
consists of a series of signalling questions assigned to the following three steps: step 
one (e.g., does a SR still address a current question?), step two (are there any new 
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relevant methods; are there any new studies or new information?), and step three 
(e.g., will the adoption of new methods or inclusion of new studies, information or 
data change findings or credibility?). If the answer to all three steps is ‘yes’ or ‘yes 
or maybe’, it is recommended that a SR be updated. The PUG suggests to update a 
SR if newly available methods (e.g., for assessing risk of bias in primary studies, 
grading evidence, pooling studies) are likely to improve the quality of the SR. This is 
consistent with the recommendations from previous research by Mayhew et al. [59] 
which discussed the evolvement of Cochrane’s Risk of Bias (RoB) tool for RCTs 
[60]. The authors advised that while updating a review, the original RoB assessments 
(done using early version of the tool) of included RCTs be replaced with those using 
the most recent version of the tool. This approach ensures methodological currency 
and facilitates consistency of assessments and reporting within and across reviews. 
This recommendation is also in line with that presented in our earlier work 
suggesting to re-assess the previously synthesised and new evidence using a newer 
methodology, provided the new methodology is an improvement over the older 
version (Publication 5) [14]. Finally, the Cochrane PUG recommend that reviewers 
use efficient search methods reflecting or adjusted for any changes in the research 
question and inclusion criteria as well as innovative technologies helping to 
streamline the review process (e.g., automation technology, machine-learning text-
mining software)[58]. 
 
Recent studies have provided additional empirical evidence by comparing the 
performance of methods in informing when (or how frequently) to update a SR. For 
example, one study demonstrated a good agreement between the Barrowman’s 
method (identifying null MAs that are ripe for updating) [43] and a new simulation-
based method [61] in prioritising 12 MAs’ updates under certain conditions 
(homogeneity, new studies consistent with those already included in a meta-analysis) 
[62]. Similarly, in a recent empirical study [63], five statistical methods and their 
extensions were compared in identifying out-of-date meta-analyses in 80 SRs 
published by the Cochrane Pregnancy and Childbirth Group between 2008 and 2010. 
The methods compared were: a) recursive CMA [48], b) CMA for sufficiency and 
stability [46], c) Barrowman’s test for identifying null meta-analyses that are ripe for 
updating [43], d) Ottawa method (quantitative signal of changes in evidence) [24], 
and e) the power of an updated MA using simulation-based power method) [61]. The 
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Ottawa method found 34 reviews as out-of-date versus seven found by using each 
the recursive CMA and Barrowman method. Two methods (CMA for sufficiency 
and stability and simulation-based power method) did not label any review as out-of-
date.  
 
7.2. Facilitating updating process  
Notwithstanding the recent methodologic developments, updating and keeping SRs 
up-to-date remains a challenging process. The absence of appropriate methodology, 
limited resources available, lack of publishing outlets and academic incentives alone 
or combination may be responsible for many SRs remaining out-of-date.     
 
There is a wide variability across studies in when SRs become out-of-date, ranging 
from 2 to 6 years, which may be explained by multifactorial nature and complexity 
of updating as a construct (e.g., the pace of development in literature, emergence of 
quantitative and qualitative signals, available resources, strength of evidence, 
healthcare burden, nature of the condition). Therefore, currently there is no fast and 
accurate decision tool or approach, which would help to predict when any SR 
becomes out-of-date or determine the most optimal time when to update a SR. 
Decision tools for updating, including regression-based algorithms that consider the 
multifactorial nature of the updating construct need to be developed and validated.  
 
In order to extend the currency of SRs, more efforts should be put towards reducing 
the time needed to produce and publish SRs [4]. Besides using the methods for 
expediting the conduct of SRs, authors are recommended to update their searches 
prior to submission for publication consideration; this increases a life-span of an 
updated review. Moreover, publishers outside Cochrane should accelerate the peer-
review process. For example, Sampson et al. [34] explored 154 reviews (91 non-
Cochrane, 36 Cochrane, 27 technical reports) and found the median time-lag from 
the last search to publication was 61 weeks (inter-quartile range: 33-87), with a 
longer median time-lag for non-Cochrane journal vs. Cochrane reviews (65 weeks 
vs. 31 weeks). The median time from the last search to indexing was 74 weeks 
(inter-quartile range: 52-108).   
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In general, the updating process could be facilitated using modified but validated 
methods by restricting or bypassing any given SR step(s) (e.g., eligibility criteria, 
search strategy, study selection, data extraction, or quality assessment) [4, 64]. The 
use of such abbreviated methods including those for so called ‘rapid reviews’ have 
been extensively discussed [65-69]. More empirical evidence suggests that certain 
resource-efficient or abbreviated techniques applied to any given review step (e.g., 
inclusions criteria, search strategy) could be used while updating reviews [36, 70-
73]. For example, one efficient approach that can inform the updating process is a 
forward citation search. This technique involves the identification of new relevant 
evidence (e.g., SRs, primary studies) that cited the SR being updated or primary 
studies included in this SR. The use of forward citation searching alone will have a 
lower recall rate than the full update search of the original SR search, since not all 
relevant studies or SRs will cite the SR in question. However, this problem is likely 
to be minimised as more journals and funding agencies require that primary study 
authors consider (and consequently cite) relevant prior SRs to inform the design and 
ethical aspects of their studies. Meanwhile, it is advisable that forward citation 
searching be used in conjunction with other searches. Forward citation searching can 
be performed in Google Scholar, Web of Science, and other search platforms (e.g., 
CINAHL, PsycINFO, Social Sciences Citation Index, and Arts & Humanities 
Citation Index). 
 
Another example of the abbreviated technique applied in the updating context was 
our surveillance study, which used abbreviated search strategy (limited to five 
general and five topic-specific specialty medical journals) and a single-reviewer 
study screening and data extraction to assess the need for updating of 24 CERs by 
assigning them to low, medium, and high priority groups for updating (Publication 
6)[38]. This surveillance method proved to be an efficient and valid approach for 
updating SRs. In a recent study, Shekelle and colleagues assessed the validity of this 
surveillance method applied to nine CERs in 2009 against ‘changes/no changes’ in 
conclusions due to a complete updating of all nine CERs done in 2013[74]. 
Specifically, for each CER conclusion, the authors evaluated the degree of 
congruence (good, fair, poor) between the 2009 classifications predicted (low, 
medium, high priority for updating) and the magnitude of change in conclusions 
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after the actual update was done in 2013. The findings demonstrated a good 
concordance for 83% and good or fair concordance for 99% of the CER conclusions. 
 
 
Current developments in machine learning-based automation (or semi-automation) 
used in the SR production can be considered as another factor to benefit the 
feasibility and efficiency of updating process [4]. For example, several studies 
demonstrated reduced workload (>50%) [75, 76] and high recall rates (>70%) [77, 
78] in identifying and screening new potentially relevant studies using automation of 
citation tracking [77], alerts for newly emerged potentially relevant to SR 
publications [78], and article classification for its inclusion into a SR [76, 75].   
 
Today’s technological advances have made it possible to develop and evaluate new 
publication formats that could facilitate the updating process. Elliott and colleagues 
[79] introduced ‘living SRs,’ which are high quality online evidence summaries, 
continuously updated as new relevant evidence becomes available. This product is a 
dynamic and constantly changing online-only evidence summary which demands 
less efforts and time compared with static and sporadically updated more resource-
intensive conventional SRs. Similarly, Shanahan points out the limitations of the 
traditional publication ‘static’ format and advocates creation of a single evolving 
document for a study (starting with registration, to protocol, and extending to results 
as they become available), which would allow a prospective and transparent 
evaluation based on the hypothesis and reliable assessment of bias or selective 
reporting [80]. 
 
Making authors responsible for updating their SRs periodically had shown some 
compliance within Cochrane, but not outside Cochrane [39]. In agreement, the 
findings of our international survey on updating showed Cochrane authors to be 
more committed to updating their reviews than those of non-Cochrane reviews 
(Publication 4) [13]. Also, our findings are in line with those from a more recent 
survey of  barriers to updating (e.g., insufficient resources, lack of reviewer 
motivation, no academic credit, limited publishing formats, insufficient time, 
inability to publish SR updates in peer-reviewed journals) [33]. This survey, which 
was based on the sample of 181 SRs identified from the American College of 
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Physicians (ACP) Journal Club 2007-2008 issues, demonstrated the lack of sufficient 
resources (74.6%) and inability to publish (52.2%) as barriers to updating. Authors 
spending more than 25% of their time dedicated to SRs were more likely to update 
their review (OR=7.25, 95% CI: 1.45, 35.71) [33].  
 
Academic institutions can support updating by according academic recognition on 
par with publishing original SRs. Journals can increase publishing outlets for 
updates, for instance, when accepting a review for publication, by also committing to 
publishing any future updates. Organizations can make updates more prominent by 
tying them to the original review (Publication 4) [13]. For example, the Public 
Library of Science (PLoS) electronically links SR updates to freely available original 
reports [81].   
 
One barrier to updating is a change in authorship taking place between the original 
publication and an update or between two updates of a review. Jaidee and colleagues 
showed that reviews updated by the original authors took a far shorter median 
number of years compared to those updated by a new review team (2.5 vs. 8.6) [27]. 
Although it is recommended that a review be updated by the original review authors, 
this is often not possible for various reasons (Publication 5) [14]. Within Cochrane, 
authors who do not intend on updating their review are suggested to team with other 
authors or turn the review over to other interested authors [39]. The Cochrane PUG 
do not provide any specific clear-cut guidance regarding the authorship in relation to 
SR updates [58].  
 
Finally, harmonisation of updating efforts may be another approach for organisations 
to cooperate in updating, sharing resources and knowledge on issues of surveillance, 
conduct, reporting and policy for updating. The harmonisation of updating was 
supported by the majority of organisations responding to our survey, but such 
cooperation may be in its infancy (Publication 4) [13]. One activity of such 
harmonisation may be an establishment and maintenance of a registry for updated 
SRs linked to an international prospective register for SR protocols (PROSPERO; 
www.crd.york.ac.uk/PROSPERO/), administered by the Centre for Reviews and 
Dissemination (CRD). The availability of such registry would help to reduce the 
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overlap or unnecessary duplication across review updates and research waste [82, 
83].   
 
7.3. Future developments in updating systematic reviews 
In light of the continuously growing body and type of evidence, considerably more 
investments should be made available to further investigate issues surrounding the 
methodology of updating and keeping SRs up-to-date. More research should be 
devoted to the identification of clinical, statistical, or methodological predictors for 
the need of updating SRs. The exploration of differences in the rates of literature 
growth across clinical fields, using bibliometric methodology, is likely to provide a 
better understanding of the practical implications of different approaches to updating 
SRs.  
 
Future research needs to optimise the presentation for updates of evidence synthesis 
products. Given that users of SRs (e.g., researchers, physicians, policy makers, or 
patients) differ in their preferences as to how updated reviews should be formatted 
and presented, some consideration should be given to multiple ways of presentation 
of the same update information using graphics, tables, text, and figures. Newberry 
and colleagues [84] collected and analysed an input from different stakeholders 
regarding the usability of five different formats of executive summaries of updated 
CERs. The authors found that policy makers preferred to see clearly marked changes 
in review process and outcomes as well to have access to data analyses with 
corresponding conclusions. Physicians preferred to see the skeleton of the review 
including KQs, inclusion criteria, outcomes, and conclusions provided graphically. 
Ideally, the effective presentation of an update should be supplemented by the 
Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 
study flow diagram [85] depicting study selection processes for the original review 
as well as the review update. Based on multiple working group feedback and 
recommendations, Stovold and colleagues produced an adapted PRISMA flow 
diagram for a review update [86]. Additional research is warranted to formulate 
guidelines and checklist for reporting updated SRs as an extension of PRISMA.      
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Other existing gaps in the evidence warranting future research are methods for 
updating qualitative reviews [87] as well as those for updating relatively novel types 
of quantitative data synthesis products such as reviews of individual participant data 
(IPD) [88] and network meta-analysis (NMA) [89, 90].   
 
Similarly, it might be worthwhile exploring the application of methods developed in 
different fields for their potential utility to inform when and/or how to update SRs. 
For example, economists developed the Value-of-Information analysis (VOI) [91]. 
Using this approach, it may be assumed that there is some value in updating (even if 
the results of the review remain unchanged), the value which relates to the reduced 
uncertainty associated with decision-making favouring the option of updating.  Thus, 
the value of information corresponding to any update of a SR would indicate the 
appropriateness of updating seen as a trade-off between the resources required and 
the magnitude of the reduction in uncertainty associated with any further 
information. Thus, the VOI analysis applied to an updating decision would allow the 
calculation of the cost-effectiveness ratio for updating any given review (i.e., the 
ratio of total costs associated with updating per expected net benefit to a population 
from updating a review). Then, reviews could be ranked in order of increasing cost-
effectiveness ratios which would correspond to decreasing updating priority [92].   
 
Updating SRs will have an important role in future in increasing the value of and 
reducing waste from scientific research. In their viewpoint “Avoidable waste in the 
production and reporting of research evidence”, Chalmers and Glasziou estimated 
that up to 85% of research investment was ‘avoidably’ wasted [93]. The highlighted 
areas were poorly formulated research questions, inappropriate study design, 
selective publication, and inadequate reporting of research findings. In 2014, the 
Lancet published a series of articles whose authors provided recommendations as 
how to increase efficiency in conducting research and reduce the research waste [83, 
94-98]. In this context, updating and maintaining SRs current can be conceptualised 
as an input process by using efficient approaches (e.g., abbreviated methodology, 
innovative automation technologies) leading to an output of a research product with 
improved quality (i.e., updated SR). Recently, Créquit et al., demonstrated an 
example of research waste [99]. The authors conducted a living cumulative NMA of 
RCTs of second-line treatments for advanced lung cancer and showed that this 
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evidence in SRs was incomplete and out-of-date, with missing at least 40% of 
treatments, 38% of treatment comparisons, and 45% of trials. The authors suggested 
a continuously updated (i.e., living cumulative) NMA for a more complete and 
updated evidence presentation as a means of reducing the waste of research.  
 
In conclusion, beyond the goal of publishing a SR, is the need to keep its evidence 
base up-to-date. This is likely a shared scientific and ethical obligation, although 
exactly whose responsibility this is, is not immediately clear. Perhaps it should be a 
joint responsibility between the investigators conducting the SR, the journals 
publishing the reviews, and the commissioning agencies requesting them. More 
concerted research efforts are required to illuminate further knowledge gaps in the 
field of updating SRs. Similarly, more efforts are required to ascertain the potential 
benefits of developing geographically harmonized, efficient, yet valid ways of 
updating SRs. Ideally, the updating process, apart from the available resources, 
should also consider issues related to search strategy, clinical questions, public 
health, and statistical techniques to accurately reflect the complexity of the ever-
evolving evidence.    
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